Canaccord raised the firm’s price target on Phreesia (PHR) to $35 from $34 and keeps a Buy rating on the shares. The firm said they remain buyers of the shares onthe Q4 report as they believe Phreesia is a stock to own given its durable revenue, expanding margins, and improving CF profile.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHR: